alfuzosin and prazosin

alfuzosin has been researched along with prazosin in 63 studies

Research

Studies (63)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (3.17)	18.7374
1990's	16 (25.40)	18.2507
2000's	25 (39.68)	29.6817
2010's	16 (25.40)	24.3611
2020's	4 (6.35)	2.80

Authors

Authors	Studies
Bondinell, WE; Hieble, JP; Ruffolo, RR	1
Ballard, S; Blagg, J; Fox, D; Kenny, B	1
Pedretti, A; Testa, B; Villa, L; Vistoli, G	1
Kinsella, GK; Rodriguez, F; Rozas, I; Watson, GW	1
Lombardo, F; Obach, RS; Waters, NJ	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bansal, R; Malhotra, A	1
Kondo, S; Morita, T	1
Chapple, CR	2
Deering, AH; Harron, DW; McMahon, MT; Scott, MG; Shanks, RG	1
Ramage, AG	1
Blondin, P; Buzelin, JM; Hebert, M	1
Ferretti, S; Larosa, M; Salsi, P; Simonazzi, M	1
Carter, AJ; Greengrass, PM; Kenny, BA; Naylor, AM; Read, AM; Wyllie, MG	1
Benavides, J; Claustre, Y; Rouquier, L	1
Gautier, E; Hicks, PE; Langer, SZ; Lechaire, J; Lefèvre-Borg, F; Manoury, P; O'Connor, SE; Pierre, F; Pimoule, C; Schoemaker, H	1
Cavallini, G	1
Chalmers, DH; Kenny, BA; Miller, AM; Naylor, AM; O'Connell, J; Williamson, IJ	1
Auguet, M; Chabrier, PE; Guilmard, C	1
Andersson, KE; Lepor, H; Wyllie, MG	1
Fernández Arjona, M; Fernández Borrell, A; Gómez Sancha, F; Mínguez Martínez, R; Peinado Ibarra, F; Pereira Sanz, I	1
Djavan, B; Marberger, M	1
Fourcade, RO	1
Clifford, GM; Farmer, RD	1
de la ROSETTE, JJ; Floratos, DL; Kiemeney, LA; Kortmann, BB; Rossi, C; Sonke, GS; Wijkstra, H	1
Cotecchia, S; Goepel, M; Hein, P; Michel, MC	1
De la Rosette, JJ; Farmer, RD; Herings, RM; Leufkens, HG; Man in 't Veld, AJ; Souverein, PC	1
de la Rosette, JJ; Floratos, DL; Kiemeney, LA; Kortmann, BB; Rossi, C; Sonke, GS	1
Niu, CQ; Ren, LM	1
Romics, I	1
Brown, GA; Sussman, DO	1
Hou, SK; Liu, SJ; Wang, XF; Wang, YC; Xu, KX	1
Akbay, E; Bozlu, M; Cayan, S; Görür, S; Ulusoy, E	1
Afshari, NA; Schwinn, DA	1
Nagano, M; Osada, Y; Yamaguchi, T	1
Michel, MC; Noguchi, Y; Ohtake, A; Okutsu, H; Sasamata, M; Someya, A; Suzuki, M; Ukai, M; Watanabe, M; Yanai-Inamura, H; Yuyama, H	1
O'Leary, MP	1
Albo, G; Berardi, F; Colabufo, NA; Contino, M; de Rienzo, G; Niso, M; Pagliarulo, A; Pagliarulo, V; Perrone, R	1
Noguchi, Y; Ohtake, A; Sasamata, M; Suzuki, M	1
Adayener, C; Akyol, I; Ates, F; Iseri, C; Senkul, T; Yilmaz, O	1
Mamalis, N	1
Bar-Yosef, Y; Kaver, I; Laufer, M; Mabjeesh, NJ; Matzkin, H; Neulander, EZ	1
Chatterjee, M; Gupta, D; Gupta, S; Nanda, K; Ray, A; Singh, R; Tiwar, A	1
Hoyano, Y; Kobayashi, S; Kusama, H; Maruyama, K; Tomiyama, Y; Yamazaki, Y	1
Adomat, H; Elterman, DS; Fleshner, N; Guns, E; Hersey, K; Lawrentschuk, N; Wood, CA	1
Chatziralli, IP; Sergentanis, TN	1
Alan, C; Eren, AE; Ersay, AR; Ertung, Y; Kırılmaz, B; Koçoğlu, H	1
Du, H; He, L; Ren, J; Wang, S	1
Hill, TM; McEwen, C; Sherman, JJ; Welch, RW	1
Ahmed, S; El Zohny, SA; Mohamed, NA	1
Barkin, J; Berner, T; Diles, D; Franks, B	1
Creta, M; Ficarra, V; Fusco, F; Giannarini, G; Longo, N; Mirone, V; Novara, G; Palmieri, A; Verze, P	1
Anoopkumar-Dukie, S; Chess-Williams, R; Forbes, A; McDermott, C	1
He, F; Li, GZ; Liu, N; Man, LB	1
Hammad, MA; Omar, MA; Salman, BI	2
Derayea, SM; Hammad, MA; Mohamed, AA; Mohamed, AI; Omar, MA	1
Aboukhashaba, A; Fainberg, J; Gaffney, C; Kashanian, J; Khan, A; Pierce, H	1
Hori, Y; Ohyama, K; Sugiura, M	1
Dahm, P; Hwang, EC; Koziarz, A; Kuntz, GM; Oestreich, MC; Sathianathen, NJ; Scales, CD; Vernooij, RW	1
Liu, L; Narayanan, NS; Pottegård, A; Simmering, JE; Welsh, MJ	1

Reviews

15 review(s) available for alfuzosin and prazosin

Article	Year
Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification. Journal of medicinal chemistry, 1995, Sep-01, Volume: 38, Issue:18 Topics: Animals; Humans; Molecular Biology; Molecular Structure; Radioligand Assay; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta	1995
Pharmacological options in the treatment of benign prostatic hyperplasia. Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship	1997
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Therapeutic progression of quinazolines as targeted chemotherapeutic agents. European journal of medicinal chemistry, 2021, Feb-05, Volume: 211 Topics: Animals; Antineoplastic Agents; Cell Proliferation; Enzyme Inhibitors; Humans; Molecular Structure; Neoplasms; Quinazolines	2021
Prostatic alpha 1-adrenoceptors and uroselectivity. The Prostate, 1997, Feb-15, Volume: 30, Issue:3 Topics: Adrenergic alpha-Antagonists; Animals; Doxazosin; Humans; Male; Prazosin; Prostate; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	1997
[Alpha blockers in the treatment of benign hyperplasia of the prostate]. Revista clinica espanola, 1997, Volume: 197, Issue:5 Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Indoramin; Male; Phenoxybenzamine; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	1997
Pharmacotherapy for benign prostatic hyperplasia--the potential for alpha 1-adrenoceptor subtype-specific blockade. British journal of urology, 1998, Volume: 81 Suppl 1 Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Doxazosin; Hormones; Humans; Male; Patient Selection; Plant Extracts; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	1998
A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. European urology, 1999, Volume: 36, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Controlled Clinical Trials as Topic; Dizziness; Dose-Response Relationship, Drug; Doxazosin; Humans; Hypotension, Orthostatic; Male; Middle Aged; Prazosin; Prognosis; Prostatic Hyperplasia; Quinazolines; Treatment Outcome; Urologic Diseases	1999
Medical therapy for benign prostatic hyperplasia: a review of the literature. European urology, 2000, Volume: 38, Issue:1 Topics: Adrenergic alpha-Antagonists; Doxazosin; Finasteride; Humans; Indoramin; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2000
[Pharmacologic treatment of benign prostatic hyperplasia]. Orvosi hetilap, 2003, Sep-14, Volume: 144, Issue:37 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2003
Treatment and pharmacologic management of BPH in the context of common comorbidities. The American journal of managed care, 2006, Volume: 12, Issue:5 Suppl Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Cardiovascular Diseases; Comorbidity; Doxazosin; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Global Health; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome	2006
[Alpha blockers in use for symptomatic benign prostatic hyperplasia--are all drugs born equal?]. Harefuah, 2008, Volume: 147, Issue:6 Topics: Adrenergic alpha-Antagonists; Doxazosin; Evidence-Based Medicine; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2008
Risk factors for intraoperative floppy iris syndrome: a meta-analysis. Ophthalmology, 2011, Volume: 118, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Diabetes Complications; Doxazosin; Humans; Hypertension; Incidence; Intraoperative Complications; Iris; Iris Diseases; Odds Ratio; Phacoemulsification; Prazosin; Quinazolines; Risk Factors; Sulfonamides; Syndrome; Tamsulosin	2011
α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies. European urology, 2016, Volume: 69, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Trials as Topic; Doxazosin; Humans; Indoles; Male; Naphthalenes; Piperazines; Prazosin; Prostatism; Quinazolines; Severity of Illness Index; Sulfonamides; Tamsulosin; Urodynamics	2016
Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults. The Cochrane database of systematic reviews, 2020, 11-12, Volume: 11 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxazosin; Humans; Indoles; Kidney Calculi; Lithotripsy; Middle Aged; Prazosin; Quinazolines; Randomized Controlled Trials as Topic; Tamsulosin; Ureteral Calculi	2020

Trials

4 trial(s) available for alfuzosin and prazosin

Article	Year
Haemodynamic and pharmacokinetic evaluation of alfuzosin in man. A dose ranging study and comparison with prazosin. European journal of clinical pharmacology, 1989, Volume: 37, Issue:1 Topics: Adult; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Half-Life; Heart Rate; Hemodynamics; Humans; Male; Norepinephrine; Prazosin; Quinazolines; Random Allocation; Time Factors	1989
Alpha-blocking treatment with alfuzosin in symptomatic benign prostatic hyperplasia: comparative study with prazosin. The PRAZALF Group. British journal of urology, 1993, Volume: 72, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Double-Blind Method; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quinazolines; Urination; Urination Disorders	1993
Alpha-1 blockade pharmacotherapy in primitive psychogenic premature ejaculation resistant to psychotherapy. European urology, 1995, Volume: 28, Issue:2 Topics: Adrenergic alpha-Antagonists; Adult; Cross-Over Studies; Double-Blind Method; Ejaculation; Humans; Male; Middle Aged; Prazosin; Psychotherapy; Quinazolines; Sexual Dysfunctions, Psychological	1995
[Efficiency and tolerance of terazosine in ambulatory patients with benign prostatic hypertrophy: comparative randomized and double-blind trial versus alfuzosin. The MG Terazosine Group]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2000, Volume: 10, Issue:2 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Ambulatory Care; Double-Blind Method; Humans; Male; Prazosin; Prostatic Hyperplasia; Quality of Life; Quinazolines; Severity of Illness Index	2000

Other Studies

44 other study(ies) available for alfuzosin and prazosin

Article	Year
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses. Journal of medicinal chemistry, 2005, Jul-28, Volume: 48, Issue:15 Topics: Chemical Phenomena; Chemistry, Physical; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Receptors, Adrenergic, alpha-1; Solvents	2005
Computational approach to the basicity of a series of alpha1-adrenoceptor ligands in aqueous solution. Bioorganic & medicinal chemistry, 2007, Apr-15, Volume: 15, Issue:8 Topics: Chemical Phenomena; Chemistry, Physical; Computational Biology; Databases, Factual; Epinephrine; Guanidine; Hydrogen-Ion Concentration; Imidazoles; Kinetics; Ligands; Molecular Conformation; Norepinephrine; Receptors, Adrenergic, alpha-1; Solutions; Thermodynamics; Vasoconstrictor Agents; Water	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
[Comparison of selective alpha-1 blockades for alpha-receptors in human hypertrophied prostatic adenomas]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1992, Volume: 83, Issue:3 Topics: Adenoma; Adrenergic alpha-Antagonists; Aged; Humans; Male; Piperazines; Prazosin; Prostatic Hyperplasia; Prostatic Neoplasms; Quinazolines; Radioligand Assay; Receptors, Adrenergic, alpha	1992
Alfuzosin for benign prostatic hypertrophy. Lancet (London, England), 1991, Jul-20, Volume: 338, Issue:8760 Topics: Adrenergic alpha-Antagonists; Drug Administration Schedule; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Urodynamics	1991
A comparison of the effects of doxazosin and alfuzosin with those of urapidil on preganglionic sympathetic nerve activity in anaesthetised cats. European journal of pharmacology, 1986, Oct-07, Volume: 129, Issue:3 Topics: Action Potentials; Animals; Blood Pressure; Cats; Doxazosin; Male; Piperazines; Prazosin; Quinazolines; Receptors, Adrenergic, alpha; Sympathetic Nervous System; Vascular Resistance	1986
[Use of terazosin and alfuzosin in the treatment of benign prostatic hypertrophy (BPH): our experience]. Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma, 1994, Volume: 65, Issue:1-2 Topics: Adrenergic alpha-Antagonists; Aged; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quinazolines; Time Factors	1994
Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog. Urology, 1994, Volume: 44, Issue:1 Topics: Adrenergic alpha-Antagonists; Affinity Labels; Anesthesia, Endotracheal; Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Doxazosin; Male; Models, Biological; Phenylephrine; Piperazines; Prazosin; Pressure; Prostate; Quinazolines; Sulfonamides; Tamsulosin	1994
Alpha 1-adrenoceptor antagonists differentially control serotonin release in the hippocampus and striatum: a microdialysis study. European journal of pharmacology, 1994, Aug-11, Volume: 261, Issue:1-2 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Extracellular Space; Hippocampus; Male; Microdialysis; Neostriatum; Perfusion; Prazosin; Quinazolines; Rats; Rats, Sprague-Dawley; Serotonin	1994
Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tract. British journal of pharmacology, 1993, Volume: 109, Issue:4 Topics: Adenofibroma; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Cats; Decerebrate State; Electric Stimulation; Female; Heart; Humans; In Vitro Techniques; Male; Phenylephrine; Prazosin; Prostatic Neoplasms; Quinazolines; Rabbits; Rats; Sympathetic Nervous System; Tumor Cells, Cultured; Urethra; Urinary Tract; Vasoconstriction	1993
Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies. British journal of pharmacology, 1996, Volume: 118, Issue:4 Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Doxazosin; Humans; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Prazosin; Pressure; Prostate; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	1996
Pharmacological characterization of alpha 1-adrenoceptor subtype mediating regulation of arterial pressure and urethral perfusion pressure in the anaesthetized rat. Journal of autonomic pharmacology, 1996, Volume: 16, Issue:4 Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Dose-Response Relationship, Drug; Linear Models; Male; Phenylephrine; Prazosin; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Urethra	1996
alpha-Blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it. The Journal of urology, 2001, Volume: 165, Issue:1 Topics: Adrenergic alpha-Antagonists; Humans; Male; Middle Aged; Prazosin; Quinazolines; Severity of Illness Index; Sulfonamides; Tamsulosin; Time Factors; Urinary Bladder Neck Obstruction; Urodynamics	2001
A quantitative analysis of antagonism and inverse agonism at wild-type and constitutively active hamster alpha1B-adrenoceptors. Naunyn-Schmiedeberg's archives of pharmacology, 2001, Volume: 363, Issue:1 Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Cell Line; Chromones; Cricetinae; Dose-Response Relationship, Drug; Doxazosin; Fibroblasts; Inositol Phosphates; Phenethylamines; Prazosin; Quinazolines; Rats; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tetralones; Tritium	2001
Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH): methodological considerations. Journal of clinical epidemiology, 2001, Volume: 54, Issue:5 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Adult; Aged; Bias; Cardiovascular Diseases; Case-Control Studies; Finasteride; Humans; Male; Middle Aged; Morbidity; Netherlands; Prazosin; Prognosis; Prostatic Hyperplasia; Quinazolines; Research Design; Risk Factors; Sulfonamides; Tamsulosin	2001
Long-term risk of re-treatment of patients using alpha-blockers for lower urinary tract symptoms. The Journal of urology, 2002, Volume: 167, Issue:4 Topics: Adrenergic beta-Antagonists; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quinazolines; Risk Factors; Sulfonamides; Tamsulosin; Time Factors; Treatment Failure	2002
[Chiral separation and preparation of three new antagonists of alpha 1-adrenoceptors by chiral mobile phase HPLC]. Yao xue xue bao = Acta pharmaceutica Sinica, 2002, Volume: 37, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Chromatography, High Pressure Liquid; Doxazosin; Molecular Structure; Prazosin; Quinazolines	2002
A current review of medical therapy for benign prostatic hyperplasia. The Journal of the American Osteopathic Association, 2004, Volume: 104, Issue:2 Suppl 2 Topics: Adrenergic alpha-Antagonists; Algorithms; Azasteroids; Cholestenone 5 alpha-Reductase; Doxazosin; Drug Therapy, Combination; Dutasteride; Finasteride; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Urination Disorders	2004
[The growth inhibition effect of alpha-adrenoceptor antagonists on androgen- independent prostate cancer cell line]. Zhonghua wai ke za zhi [Chinese journal of surgery], 2004, May-22, Volume: 42, Issue:10 Topics: Adrenergic alpha-Antagonists; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Humans; Male; Phenoxybenzamine; Prazosin; Prostatic Neoplasms; Quinazolines	2004
A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes. Scandinavian journal of urology and nephrology, 2004, Volume: 38, Issue:5 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cohort Studies; Diabetes Mellitus; Doxazosin; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Probability; Prostatic Hyperplasia; Quinazolines; Reference Values; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics	2004
Alpha1-adrenergic antagonists and floppy iris syndrome: tip of the iceberg? Ophthalmology, 2005, Volume: 112, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Doxazosin; Humans; Intraoperative Complications; Iris Diseases; Phacoemulsification; Prazosin; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin	2005
Effects of different alpha-1 adrenoceptor blockers on proximal urethral function using in vivo isovolumetric pressure changes. Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 2005, Volume: 41, Issue:5 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cardiovascular System; Male; Phenylephrine; Prazosin; Quinazolines; Rabbits; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Urethra	2005
In vivo studies on the effects of alpha1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits. Naunyn-Schmiedeberg's archives of pharmacology, 2006, Volume: 372, Issue:5 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Dose-Response Relationship, Drug; Doxazosin; Male; Prazosin; Pupil; Quinazolines; Rabbits; Receptors, Adrenergic, alpha-1; Time Factors; Urethra	2006
Human epididymal and prostatic tracts of vas deferens: different contraction response to noradrenaline stimulation in isolated organ bath assay. European journal of pharmacology, 2007, Dec-22, Volume: 577, Issue:1-3 Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Aged; Dose-Response Relationship, Drug; Doxazosin; Epididymis; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; Norepinephrine; Organ Specificity; Prazosin; Prostate; Quinazolines; Stimulation, Chemical; Vas Deferens	2007
In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs. European journal of pharmacology, 2008, Feb-02, Volume: 580, Issue:1-2 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Dogs; Dose-Response Relationship, Drug; Ejaculation; Indoles; Male; Naphthalenes; Phenylephrine; Piperazines; Prazosin; Pressure; Prostate; Quinazolines; Sulfonamides; Tamsulosin; Urethra; Vas Deferens	2008
Comparing the therapeutic outcome of different alpha-blocker treatments for BPH in the same individuals. International urology and nephrology, 2008, Volume: 40, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Prazosin; Prostate-Specific Antigen; Prostatic Hyperplasia; Quinazolines; Treatment Outcome	2008
Intraoperative floppy-iris syndrome associated with systemic alpha blockers. Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:7 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Doxazosin; Humans; Intraoperative Complications; Iris Diseases; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Syndrome; Tamsulosin	2008
Functional screening of adrenergic receptors by measuring intracellular calcium using the FlexStation scanning fluorimeter. Biotechnology journal, 2009, Volume: 4, Issue:3 Topics: Animals; Biotechnology; Calcium; Cell Line; Dose-Response Relationship, Drug; Fluorescent Dyes; Fluorometry; GTP-Binding Proteins; Humans; Kinetics; Prazosin; Protein Binding; Quinazolines; Receptors, Adrenergic; Signal Transduction; Sulfonamides; Tamsulosin	2009
Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters. Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 2009, Volume: 45, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Cricetinae; Doxazosin; Indoles; Male; Mesocricetus; Mice; Mice, Inbred ICR; Muscle Contraction; Norepinephrine; Prazosin; Quinazolines; Ureter	2009
Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors. The Journal of urology, 2010, Volume: 183, Issue:5 Topics: Administration, Oral; Adrenergic alpha-Antagonists; Azasteroids; Capsules; Cholestenone 5 alpha-Reductase; Chromatography, High Pressure Liquid; Doxazosin; Drug Contamination; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tablets; Tamsulosin	2010
Comparison of effects of alpha receptor blockers on endothelial functions and coagulation parameters in patients with benign prostatic hyperplasia. Urology, 2011, Volume: 77, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; Blood Coagulation; Blood Pressure; Brachial Artery; Doxazosin; Endothelial Cells; Endothelium, Vascular; Humans; Male; Middle Aged; Prazosin; Prostate-Specific Antigen; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Ultrasonography	2011
Cell membrane chromatography competitive binding analysis for characterization of α1A adrenoreceptor binding interactions. Analytical and bioanalytical chemistry, 2011, Volume: 400, Issue:10 Topics: Adrenergic alpha-1 Receptor Antagonists; Binding, Competitive; Cell Line; Cell Membrane; Chromatography; Doxazosin; Humans; Methods; Phentolamine; Piperazines; Prazosin; Protein Binding; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	2011
Prescriber monitoring for benign prostatic hyperplasia within a family medicine clinic: a comparison of medication classes. Journal of pharmacy practice, 2012, Volume: 25, Issue:2 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Doxazosin; Drug Therapy, Combination; Family Practice; Humans; Indoles; Male; Middle Aged; Practice Patterns, Physicians'; Prazosin; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Sulfonamides; Tamsulosin	2012
Rapid and sensitive online determination of some selective α1-blockers by flow injection analysis with micelle-enhanced fluorescence detection. Journal of fluorescence, 2013, Volume: 23, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Flow Injection Analysis; Fluorescence; Internet; Micelles; Prazosin; Quinazolines; Spectrometry, Fluorescence; Time Factors	2013
Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence. The Canadian journal of urology, 2015, Volume: 22, Issue:4 Topics: Administrative Claims, Healthcare; Adrenergic alpha-Antagonists; Aged; Benzofurans; Doxazosin; Drug Therapy, Combination; Humans; Longitudinal Studies; Male; Mandelic Acids; Medication Adherence; Middle Aged; Muscarinic Antagonists; Ontario; Prazosin; Prostatic Hyperplasia; Prostatism; Pyrrolidines; Quinazolines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate	2015
Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines. The Prostate, 2016, Volume: 76, Issue:8 Topics: Adrenergic alpha-1 Receptor Antagonists; Antineoplastic Agents; Apoptosis; Autophagy; Cell Death; Cell Line, Tumor; Cell Survival; Doxazosin; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Male; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prazosin; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Sulfonamides; Tamsulosin	2016
Efficacy of α-blocker in improving ureteral stent-related symptoms: a meta-analysis of both direct and indirect comparison. Drug design, development and therapy, 2016, Volume: 10 Topics: Adrenergic alpha-Antagonists; Humans; Pain Measurement; Pain, Postoperative; Prazosin; Quinazolines; Stents; Treatment Outcome; Ureteral Obstruction	2016
Utility of Hantzsch reaction for development of highly sensitive spectrofluorimetric method for determination of alfuzosin and terazosin in bulk, dosage forms and human plasma. Luminescence : the journal of biological and chemical luminescence, 2017, Volume: 32, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Dosage Forms; Humans; Plasma; Prazosin; Quinazolines; Spectrometry, Fluorescence	2017
An efficient spectrofluorimetric method adopts doxazosin, terazosin and alfuzosin coupling with orthophthalaldehyde: Application in human plasma. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2018, Apr-15, Volume: 195 Topics: Doxazosin; Fluorescence; Humans; Limit of Detection; o-Phthalaldehyde; Plasma; Prazosin; Quinazolines; Spectrometry, Fluorescence	2018
Micellar enhanced spectrofluorimetric approach for nanogram detection of certain α Luminescence : the journal of biological and chemical luminescence, 2018, Volume: 33, Issue:7 Topics: Adrenergic alpha-1 Receptor Antagonists; Antihypertensive Agents; Doxazosin; Fluorescence; Humans; Limit of Detection; Micelles; Pharmaceutical Preparations; Plasma; Prazosin; Quinazolines; Spectrometry, Fluorescence; Tablets	2018
Postorgasmic illness syndrome: potential new treatment options for a rare disorder. Scandinavian journal of urology, 2020, Volume: 54, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Humans; Male; Orgasm; Prazosin; Quinazolines; Sexual Dysfunction, Physiological; Syndrome	2020
Evaluation of syncope association with α Die Pharmazie, 2019, 12-01, Volume: 74, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Doxazosin; Humans; Hypertension; Indoles; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quinazolines; Syncope; Tamsulosin	2019
Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease. JAMA neurology, 2021, 04-01, Volume: 78, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cohort Studies; Databases, Factual; Denmark; Doxazosin; Female; Follow-Up Studies; Glycolysis; Humans; Male; Middle Aged; Parkinson Disease; Prazosin; Quinazolines; Registries; Risk Factors; Tamsulosin; United States	2021